← Open Payments lookup

AISHA SABIR: Open Payments

NPI 1609970631 · CONCORD, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$793 in 51 payments from 9 companies in 2025. Trend: 2023 $406 · 2024 $791 · 2025 $793

Food & beverage: $793
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.30$251
Otsuka America Pharmaceutical, Inc.5$191
Vanda Pharmaceuticals Inc.6$145
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$97
ABBVIE INC.2$33
Janssen Pharmaceuticals, Inc1$24
Neurocrine BioSciences, Inc.1$20
E.R. Squibb & Sons, L.L.C.1$17
Alkermes, Inc.1$16

Products named: UZEDY, FANAPT, ABILIFY MAINTENA, CAPLYTA, REXULTI, VRAYLAR, ABILIFY ASIMTUFII, INVEGA SUSTENNA.

Industry payments across NH — which companies pay providers there.